Company Profiles

driven by the PitchBook Platform

Cleave Biosciences

Description

Developer of oncology pharmaceuticals targeting pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival.

2010

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$37M

Latest Deal Amount

$91M

Total Amount Raised

Description

Developer of oncology pharmaceuticals targeting pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival.

Website:

www.cleavebio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Other Pharmaceuticals and Biotechnology

Primary Office

866 Malcolm Suite 100 Burlingame, CA 94010United States +1 (650) 443-3000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Cleave Biosciences's full profile, request a free trial.

Cleave Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Cleave Biosciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Cleave Biosciences Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
5AM VenturesVenture CapitalMinority000 0000000 0000
Arcus VenturesVenture CapitalMinority000 0000000 0000
Astellas Venture ManagementCorporate Venture CapitalMinority000 0000000 0000
CelgeneCorporationMinority000 0000000 0000
Clarus VenturesVenture CapitalMinority000 0000000 0000
5AM Ventures Venture Capital
Arcus Ventures Venture Capital
Astellas Venture Management Corporate Venture Capital
Celgene Corporation
Clarus Ventures Venture Capital

Cleave Biosciences Executive Team (15)

NameTitleBoard
Seat
Contact
Info
Laura Shawver Ph.DChief Executive Officer & Board Member
Mark Rolfe Ph.DPresident & Chief Scientific Officer
Daniel AndersonDirector, Biology
Timothy SmithChief Business Officer
Laurence Lasky Ph.DScientific Co-Founder & Advisory Board
Laura Shawver Ph.D Chief Executive Officer & Board Member
Mark Rolfe Ph.D President & Chief Scientific Officer
Daniel Anderson Director, Biology
Timothy Smith Chief Business Officer
Laurence Lasky Ph.D Scientific Co-Founder & Advisory Board

Cleave Biosciences Board Members (9)

NameRepresentingRoleSinceContact
Info
Alfred Scheidegger Ph.DNextech InvestFounding Partner & Chief Executive Officer000 0000
Andrew Schwab5AM VenturesCo-Founder & Managing Partner000 0000
Carol GallagherNew Enterprise AssociatesPartner000 0000
Dennis Henner Ph.DClarus VenturesManaging Director000 0000
Jonathan Root MDUS Venture PartnersGeneral Partner000 0000
Alfred Scheidegger Ph.D Founding Partner & Chief Executive Officer Nextech Invest
Andrew Schwab Co-Founder & Managing Partner 5AM Ventures
Carol Gallagher Partner New Enterprise Associates
Dennis Henner Ph.D Managing Director Clarus Ventures
Jonathan Root MD General Partner US Venture Partners
Request full access to PitchBook